logo
Raw milk and wild birds: How the bird flu strain raising alarm in the US could enter Europe

Raw milk and wild birds: How the bird flu strain raising alarm in the US could enter Europe

Yahoo9 hours ago
A strain of bird flu that has jumped from animals to people in the United States could find its way to Europe, EU scientists have warned in a new report.
EU-US trade of 'raw milk' products and wild bird movement appear to be the biggest risks, according to the analysis from the European Food Safety Authority (EFSA).
Avian influenza has been spreading at higher levels worldwide over the past five years, including in wild birds and poultry farms in Europe. The virus has occasionally jumped from birds into mammals, including foxes, mink, and cats.
European officials are also concerned about an H5N1 bird flu outbreak among US dairy cows that spilled to people last year, infecting 70 and killing one.
There is no evidence of person-to-person transmission, and the US strain has not been detected in the EU. But health experts fear that left unchecked, the virus could evolve to the point where it spreads more easily between people, raising the risk of a broader outbreak.
'Avian influenza viruses pose an increasing threat, with the potential to adapt to humans and trigger future pandemics,' Andrea Gervelmeyer, a scientific officer with EFSA's animal health team, told Euronews Health.
Related
EU keeps racing pigeons tethered as bird flu ruffles feathers
That, Gervelmeyer added, is a 'major concern for global health'.
For the new report, EFSA analysed all the possible ways the US bird flu strain could make its way into the EU.
One risk is that as wild birds migrate in the coming months, they could bring H5N1 with them. The virus might be detected first in key European stopovers such as Iceland, the United Kingdom, Ireland, western parts of Scandinavia, and major wetlands on the coasts of Germany, Denmark, and the Netherlands.
EFSA scientists also scrutinised trade between the EU and US.
Related
Bird flu cases spreading faster and with greater impacts - report
Imports of 'raw' milk, cheese, or other dairy products pose a 'potential risk for virus introduction into the EU,' they said.
Raw milk products may be properly labelled or pasteurised, a process that kills bacteria and viruses such as avian influenza. That means dairy exports from parts of the US hit hard by the outbreak could be riskier.
Since 2023, the EU has imported 889 tonnes of milk and cream and 10 tonnes of fresh cheese from the US that 'may not have undergone sufficient thermal treatment' to kill the virus, EFSA said.
The EU also imports about 20,000 tonnes of beef from the US every year. But strict trade rules and limited presence of the virus in meat mean that while it is theoretically possible the bird flu strain could enter Europe that way, it's not likely, EFSA said.
Related
Is Europe doing enough to prepare for the potential threat of bird flu to humans?
Scientists also do not believe that US exports of chicken, poultry, or bull semen – of which the EU has imported nearly 85,000 kilograms since 2023 – are likely to cause bird flu outbreaks in Europe.
However, there is still some 'uncertainty' around data from the US, the agency said, and it will keep monitoring bird flu threats and issue recommendations to keep the US strain from entering the EU.
For now, Gervelmeyer said the risk assessment should help to boost 'preparedness measures to protect public health in Europe'.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Could UK Tap Water's 'Forever Chemicals' Lead To France-Style Bans?
Could UK Tap Water's 'Forever Chemicals' Lead To France-Style Bans?

Yahoo

time8 hours ago

  • Yahoo

Could UK Tap Water's 'Forever Chemicals' Lead To France-Style Bans?

France has seen its biggest ever ban on tap water in Saint-Louis, near the Swiss city of Basel. Local authorities put letters through approximately 60,000 mailboxes urging the public to ensure that kids under two, pregnant and breastfeeding people, and the immunocompromised don't drink tap water. This was because the levels of PFAs, also known as 'forever chemicals,' had been raised to four times the acceptable limit by firefighting foam used in a local airport since the '60s. PFAS stand for per- and polyfluoroalkyl substances, chemicals which take an extremely long time to break down. They're present in everything from skincare products to frying pans and include 5,000+ substances. Saint-Louis is one of thousands of EU water sources suspected to be contaminated by too many PFAs, the overconsumption of which may be linked to increased cancer risk, reproductive issues, compromised immune systems, and even heightened cholesterol levels. Given that 'from 2018 to 2022, 51-60% of rivers, 11-35% of lakes and 47-100% of transitional and coastal waters exceeded the annual average environmental quality standards (EQS) for PFOS [a specific PFAS]' in Europe, we thought we'd ask what that might mean for the UK. Speaking to HuffPost UK, Professor Sir Colin Berry, Emeritus Professor of Pathology at the Queen Mary University of London, offered some reassurance. 'It is worth emphasising the reason that these compounds [PFAS] are persistent is that they are non-reactive; the chances that the very small amounts found will have detectable adverse effect if ingested is vanishingly small,' the former President of the European Society of Pathology told us. 'The levels are set as precautionary values and are more to do with control of contamination than concern about health,' he added. The Drinking Water Inspectorate says that, 'Based on our current knowledge, the low levels of PFAS detected in some untreated water abstracted for public drinking water supplies has no acute or immediate impact on human health.' Still, a 2023 evaluation by the World Health Organisation concluded that teo PFAS (perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS)) can be considered carcinogenic and possibly carcinogenic, respectively. PFOAs are group 1 carcinogens per the WHO's cancer research sector, IARC, along with processed meat, tobacco, and asbestos. PPOS are group 2B 'possible' carcinogens, along with aloe vera, coconut oil, and pickled vegetables. Doctors have previously criticised the IARC cancer grouping system for not considering 'the level of risk relative to the dosage,' which they think may have led to the body grouping things like salted fish in the same group 1 carcinogen class as plutonium. Whatever the disputed effects of going over the EU's limit of PFAS may be, Dr Shubhi Sharma, a Scientific Research Assistant at CHEM Trust, says parts of the UK certainly do that. 'PFAS have already been found in almost 200 untreated drinking water samples in England and the levels in these samples were found to be above the Drinking Water Inspectorate's PFAS threshold guidance for England and Wales, which is a 'wholesomeness' value of 0.1 ug/l for 48 PFAS,' she told us. A Ministry of Defence spokesperson told The Guardian in response to those claims that 'Ensuring the safety of our staff, personnel and the public is our number one priority and that's why we are complying with the relevant legislation and regulations. 'As understanding of these chemicals has changed, we have responded accordingly. We have prioritised a programme of investigation of our sites, which has been agreed with the Environment Agency.' The CHEM Trust researcher said England and Wales 'have no statutory limits on PFAS in drinking water – the water companies just need to test for 48 PFAS, but this is a non-binding guidance. Scotland, on the other hand, adheres to EU standards, which are far stricter than the UK guidelines.' Member states of the EU, she added, will need to comply with the Drinking Water Directive thresholds by 12th January 2026. 'People in [the] UK have different threats of exposure to PFAS in their drinking water depending on whether they live in Scotland or England/Wales,' Dr Sharma added. Dr Sharma, who believes PFAS carry health risks and are a 'huge concern,' says that 'the UK needs to regulate PFAS as a group and at the very source' (mainly industrial sites). But seeing as England and Wales have no statutory limit on PFAS and Scotland sticks to the EU-recommended level, a tap water ban based on the slow-degrading chemicals seems unlikely any time soon. The Next Thing To Ruin The UK's Water Supply Isn't What You Think Tories Shamed Over UK's Polluted Water Supply: 'They Turned A Blind Eye' I've Dreaded Every Heatwave Since 2019 – And It's Only Going To Get Worse

Surmodics still recovering after June cyberattack
Surmodics still recovering after June cyberattack

Yahoo

time8 hours ago

  • Yahoo

Surmodics still recovering after June cyberattack

Surmodics has revealed that it is still recovering after it was hit by a cyberattack in June 2025. In a Form 8-K filed with the US Securities and Exchange Commission (SEC), the maker of the Pounce XL thrombectomy system for clot removal said that on 5 June, the US-based company discovered that a third party had gained unauthorised access to 'certain' IT systems, rendering them 'unavailable' to the company. Surmodics has been able to continue accepting customer orders and shipping products without any customer impact by using alternative IT systems following the breach. The company noted that to its knowledge, the threat actor had not released any of its data, including any third-party data, or used any such data for any fraudulent purposes. It continues to evaluate the 'scope and details of the IT data' stolen in the attack. Containment measures were initiated once the breach was identified, with certain IT systems taken offline. Surmodics added that it implemented its security incident response plan and that remaining IT systems and data are currently being restored and validated. Surmodics is not the only medtech company to have experienced a cyberattack this year. In May, medical technology company Masimo revealed that 'unauthorised activity' had been detected on its on-premise network in April. The incident disrupted certain activities at the patient monitoring company's manufacturing facilities and hindered its ability to process and ship customer orders effectively. According to Masimo, the attack did not affect its cloud-based hospital data systems, with no evidence of any employee or patient data being compromised. Research indicates that cyberattacks on healthcare organisations are on the rise, due in part to outdated legacy systems and increased vulnerabilities due to the rise of Internet of Things (IoT) devices and the overall richness of the data available to bad actors. According to KPMG, due to cyber threats, the functioning of healthcare systems has reached a 'tipping point'. With the rise of AI-powered medical transcription tools being deployed in healthcare systems, KPMG states that there is an increasing onus on chief information security officers (CISOs) to ensure that data privacy, access management, and other security protocols are well-developed as a means to protect sensitive patient information. According to GlobalData, cybersecurity spending by healthcare providers is growing at a CAGR of 12.5% to reach a valuation of $10.9bn by 2027. "Surmodics still recovering after June cyberattack" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery
$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery

Yahoo

time9 hours ago

  • Yahoo

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery

DELRAY BEACH, Fla., July 3, 2025 /PRNewswire/ -- What's fueling the shift from sterilization to scalability? The global single-use surgical instruments market, valued at US$5.60 billion in 2024, stood at US$5.92 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.80 billion by the end of the period. This growth is being driven by the rise of minimally invasive, short-stay, and outpatient surgeries—procedures that demand efficiency, sterility, and speed. Disposable tools are no longer just convenient—they are mission-critical assets for modern surgical care. Download PDF Brochure: Why are single-use surgical instruments becoming a new clinical benchmark? In high-risk surgeries such as general, ophthalmic, dental, and cardiovascular procedures, hospitals are under pressure to minimize infection, reduce turnaround time, and ensure tool readiness. Single-use instruments meet these demands with precise, sterile, ready-to-use tools that support faster recovery, reduce complications, and align with evolving patient care models like same-day discharge and ambulatory surgery. What challenges do single-use surgical instruments solve? They solve the pressing issues of cross-contamination, procedural inefficiency, and high sterilization costs. In underserved or rural healthcare facilities, limited access to reprocessing systems makes reusable tools a risk. Single-use surgical instruments eliminate these barriers, delivering hygienic, high-performance solutions that simplify workflows and improve patient safety. Where is adoption accelerating the fastest? Emerging markets such as India, Asia Pacific, Latin America, and sub-Saharan Africa are rapidly expanding healthcare infrastructure. With India conducting over 30 million surgeries annually, the demand for disposable, low-maintenance instruments are surging. These regions offer cost-effective pathways to scale sterile surgical care across both urban and rural settings. Request Sample Pages : Who are the key leaders—and how are they gaining ground? Market frontrunners include Ethicon, Medtronic, and BD, backed by global reach and deep R&D strength. Other major players like Smith+Nephew, STERIS, and B. Braun are expanding through acquisitions, strategic partnerships, and global training centers—including Smith+Nephew's surgical innovation center in Munich and STERIS's acquisition of BD's instrumentation business. What's the biggest challenge—and how do we overcome it? High cost and environmental sustainability are key hurdles. Smaller hospitals often rely on reusable tools due to budget limits. Simultaneously, increased medical waste is drawing scrutiny. Forward-thinking suppliers will win by delivering cost-efficient, eco-conscious single-use solutions backed by clear clinical and operational ROI. What should healthcare leaders be asking now?Not "Should we switch to disposables?"—but rather:• How can we cut infection risks without compromising efficiency?• Where can we reduce operational overhead from sterilization bottlenecks?• How do single-use instruments fit into our outpatient care strategy?• Which partners best align with our compliance, safety, and growth goals? Final Thought: In Sterility, There Is Strategy. In Simplicity, There Is global shift toward safe, efficient, and rapid-turnaround surgery is here. Single-use surgical instruments deliver the hygiene, performance, and reliability modern care demands. Facilities that embrace this model will lead on patient outcomes, cost control, and regulatory compliance. In the new era of surgery—precision, performance, and protection begin with single-use. For more information, Inquire Now! Related Reports: Surgical Sutures Market Wound Care Market Biosurgery Market Knee Replacement Surgery Market Surgical Suction Instruments Market Get access to the latest updates on Top Companies in Single-use Surgical Instruments and Single-use Surgical Instruments Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store